ALZAMEND NEURO, INC.

Consensus Alzamend Neuro, Inc.

Stocks

ALZN

US02262M6057

Biotechnology & Medical Research

Market Closed - Nasdaq 21:30:00 09/10/2026 BST			5-day change	1st Jan Change
1.340 ^USD	0.00%		-2.19%	-26.37%

09-10	Alzamend Neuro, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2026	CI
08-20	Alzamend Neuro Reports Resting-State Fmri Findings For Al001 Accepted For Poster Presentation At Neuroscience 2026	CI

Evolution of the Average Target: Alzamend Neuro, Inc.

Evolution of the Average Target - Alzamend Neuro, Inc.

Evolution of the Target Price: Alzamend Neuro, Inc.

Evolution of the Target Price - Alzamend Neuro, Inc.

Changes in Analyst Recommendations: Alzamend Neuro, Inc.

acb95162cb1460494d7068bd71d4.2wchwV2MOyL4Kk7fxaxW6wfwwZebUd_3WpzZKn-JxK8.uDJ7kATJb0vJWgawr-NhoXSSiO35C-mDNvuJTgrk8Z3iVBKTPtNxVpluKQ~3871173b4125b27110f7188e7276e1ea

Analysts' recommendations: Alzamend Neuro, Inc.

12/04/23	Maxim Initiates Alzamend Neuro at Buy With $1.50 Price Target	MT
27/12/21	Ascendiant Capital Adjusts Price Target on Alzamend Neuro to $8.25 From $8, Maintains Buy Rating	MT
01/10/21	Alzamend Neuro : Ascendiant Capital Initiates Alzamend Neuro at Buy Rating With $8 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ALZAMEND NEURO, INC.			-	-	+1,840.3%
	WUXI APPTEC CO., LTD.					+20.88%
	ARGENX SE					+39.25%
	LONZA GROUP AG					+20.5%
	IQVIA HOLDINGS INC.					+13.53%
	REVOLUTION MEDICINES, INC.					+36.56%
	BEONE MEDICINES AG					+22.87%
	CELLTRION, INC.					+49.08%
	WUXI BIOLOGICS (CAYMAN) INC.					+10.4%
	BIONTECH SE					+19.76%
	Average					+207.31%
	Weighted average by Cap.					+25.86%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.340USD

Average target price

26.00USD

Spread / Average Target

+1,840.30%

High Price Target

26.00USD

Spread / Highest target

+1,840.30%

Low Price Target

26.00USD

Spread / Lowest Target

+1,840.30%

Analyst Consensus Detail

Analyst consensus - Alzamend Neuro, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Alzamend Neuro, Inc.

Stock Market
Stocks
ALZN Stock
Consensus Alzamend Neuro, Inc.

As early as today, start finding the best investment opportunities!